Thursday, Jan 20th 2022
Trending News

Covaxin for kids Bharat Biotech's partner requests approval for ages 2-18 in

By FnF Correspondent | PUBLISHED: 06, Nov 2021, 19:10 pm IST | UPDATED: 06, Nov 2021, 19:28 pm IST

Covaxin for kids Bharat Biotech's partner requests approval for ages 2-18 in New Delhi: Ocugen, Bharat Biotech's US partner, has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18. "We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners - Ocugen," tweeted Dr Raches Ella, Bharat Biotech's clinical lead for Covid-19 vaccines.

There was a tweet posted from Ocugen's social media handle as well.

Diwali came early to India as on Wednesday (November 3), the World Health Organisation (WHO)  granted approval for Emergency Use Listing (EUL) for Bharat Biotech's COVID-19 vaccine, Covaxin.The approval was done on the recommendation of the Technical Advisory Group (TAG) for Emergency Use Listing (TAG-EUL), an independent advisory panel that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.

Bharat Biotech's Covaxin and AstraZeneca and Serum Institute's Covishield are the two widely used vaccines in India. Union Health Minister Mansukh Mandaviya expressed his joy as Covaxin got the WHO nod. He had said then, "WHO today granted for Emergency Use Listing (EUL) of Made-in-India Covaxin. On this occasion, I congratulate scientists of ICMR and Bharat Biotech (the manufacturer of Covaxin)."

Meanwhile, in the United States, Pfizer's shot is the only one approved for children under the age of 18. "Filing for Emergency Use Authorization in the US for paediatric use is a significant step toward our hope to make our vaccine candidate available here and help combat the Covid-19 pandemic,” Shankar Musunuri, chairman of the board, CEO and co-founder of Ocugen was quoted as saying by the Hindustan Times. But whether this will get the FDA nod, only time will tell.

You Might also Like
Editor's Blog

Lest we forget... lets give 2022 a chance

by : Priti Prakash

Like others, we too are a nation that is in the race of calling ourselves 'New India'. The...

Quick Vote

How is the economic policy of the Modi government?